486439-05-8

Upstream product

• 120-43-4 4-ethoxycarbonylpiperazine 
• 937-20-2 p-chlorophenacyl chloride 
• 536-38-9 4-chlorobenzoylmethyl bromide 

Downstream Products

• 199468-11-6 1-(4-chlorophenyl)-2-piperazine-1-yl-ethanone 
• 486439-07-0 4-[2-(4-chloro-phenyl)-2-hydroxy-ethyl]-piperazine-1-carboxylic acid ethyl ester 
• 199467-52-2 AM 36 
• 486439-11-6 4-[2-(4-chloro-phenyl)-2-(4-methyl-piperazin-1-yl)-ethyl]-piperazine-1-carboxylic acid ethyl ester 
• 486439-17-2 1-[1-(4-Chloro-phenyl)-2-piperazin-1-yl-ethyl]-4-methyl-piperazine 
• 486439-09-2 4-[2-chloro-2-(4-chloro-phenyl)-ethyl]-piperazine-1-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

Structure-activity relationship of (1-Aryl-2-piperazinylethyl) piperazines: Antagonists for the AGRP/melanocortin receptor binding

Agouti-related protein (AGRP) is an endogenous antagonist of the melanocortin action. In the hypothalamus, melanocortin peptide agonists act as satiety-inducing factors that mediate their action through the melanocortin-4 receptor (MC4R) whereas AGRP is a

Cyclic voltammetry as an indicator of antioxidant activity

A series of compounds based around combining the neuroprotective properties of non-competitive N-methyl D-aspartic acid (NMDA) receptor antagonists with antioxidant functionalities have been prepared. The redox chemistry of these compounds has been evalua